Immune & Autoimmune Testing
Hidden delayed allergies can cause over 900 autoimmune variants or immune dysfunction symptoms and conditions. Read about successful patient outcomes in difficult clinical cases through use of the LRA by ELISA/ACT tests and treatment plans. Asthma Case Study Attention Deficit Hyperactivity Disorder (ADHD) Case Study 1 Attention Deficit Hyperactivity Disorder (ADHD) Case Study 2 Chronic Acne Case Study Chronic Fatigue and Fibromyalgia Case Study Chronic Fatigue (CFIDS) Case Study Diabetes Case Study Endometriosis Case Study Fibromyalgia (FM) Case Study Irritable Bowel Syndrome (IBS) Case Study Irritable Bowel Syndrome (IBS) Case Study Update Migraines Case Study Psoriasis Case Study Rhinitis Case Study Ulcerative Colitis (UC) Case Study Sjogren's Syndrome Case Study Temporal Arteritis Case Study Thyroiditis Case Study 1 Thyroiditis Case Study 2 |
Autoimmunity means reflexive attack by the immune system on its host. Autoimmune conditions are characterized by lymphocytic, mononuclear cellular infiltrates in areas of active disease. Person-specific determinations of lymphocyte response assays (LRA by ELISA/ACT) open a more advanced, comprehensive, functional, ex vivo system of tests. Chronic autoimmune conditions are usually characterized by inflammation, focal or systemic swelling, pain, and cumulative repair deficit. Examples of autoimmune conditions range from diabetes and Addison’s syndrome to thyroiditis and lupus (SLE), from eczema and psoriasis to allergic migraine headaches and multiple sclerosis, from asthma and pneumonitis to myocarditis and pericarditis, from rheumatoid arthritis to connective tissue syndromes, from glomerulonephritis to interstitial cystitis, from ulcerative colitis (UC) to regional enteritis (RE) to irritable bowel syndrome (IBS), from Sjogren’s syndrome to hepatitis, from uveitis to vasculitis, from myofascial pain syndromes to fibromyalgia (FM), from mitochondrial dysfunction syndrome (MDS) to chronic fatigue immune dysfunction syndrome (CFIDS). Autoimmunity: Clinical relevance of biological response modifiers in diagnosis, treatment, and testing, Part 1 Autoimmunity and cofactor replacement, Part 2 Immune Defense and Repair Systems, Part 1 Immune Defense and Repair Systems, Part 2 Immune Defense and Repair Systems, Part 3 Immune Defense and Repair Systems, Part 4 Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease Mechanisms of Disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases The Biochemical-Immunology Window: A Molecular View of Psychiatric Case Management IBS and Dairy Sensitivity Increased Need for Heavy Metal Testing Using LRA by ELISA/ACT Vitamin C-rich diet may slash diabetes risk Immune Dysfunction Diseases One of the recent major advancements in medicine is our expanded understanding of the immune system and its important role in general health and wellness. Medical science has come to recognize that the immune system has defense as well as repair components. The defense component of the immune system fights off the foreign “invaders” that create disease, while the repair component restores tissue and organs from damage that the disease state may have caused. If either the defense or repair function becomes overburdened or overstressed, immune dysfunction and disease may result. Recent studies have shown that when the defense elements (lymphocytes) are mobilized against the effects of foreign antigens, the vital repair process is deferred. Organs and tissue weaken over time, and the body’s ability to fight off future assaults is reduced. The effect of immune system dysfunction can be chronic inflammatory and autoimmune diseases that often defy treatment. Digestive remnants and environmental antigens are the most common assaults that pose the greatest burden to our immune system on a daily basis. By identifying these harmful antigens and eliminating exposure through the LRA by ELISA/ACT program, the immune burden can be reduced or eliminated, allowing the defense and repair systems to return to optimal function. The result is improved, sustainable health. Autoimmunity: Clinical relevance of biological response modifiers in diagnosis, treatment, and testing, Part 1 Autoimmunity and cofactor replacement, Part 2 Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease Mechanisms of Disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases http://www.elisaact.com/test/nonhc/idd.asp |